Composition and method for treating neurological disease
US8889740B1 · kind B1 · utility
21Cited by
56References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2014 |
| Grant date | Nov 18, 2014 |
| Priority date | — |
| Expiry date | Aug 4, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and one or more excipients, wherein at least one of the excipients modifies release of amantadine. Methods of administering the same are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.